Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Medicina (B.Aires) ; 74(3): 185-188, jun. 2014.
Article in Spanish | LILACS, BINACIS | ID: biblio-1165184

ABSTRACT

In cancer, B cells have been classically associated with antibody secretion, antigen presentation and T cell activation. However, a possible role for B lymphocytes in impairing antitumor response and collaborating with tumor growth has been brought into focus. Recent reports have described the capacity of B cells to negatively affect immune responses in autoimmune diseases. The highly immunogenic mouse tumor MCC loses its immunogenicity and induces systemic immune suppression and tolerance as it grows. We have previously demonstrated that MCC growth induces a distinct and progressive increase in B cell number and proportion in the tumor draining lymph nodes (TDLN), as well as a less prominent increase in T regulatory cells. The aim of this research was to study B cell characteristics and function in the lymph node draining MCC tumor and to analyze whether these cells may be playing a role in suppressing antitumor response and favoring tumor progression. Results indicate that B cells from TDLN expressed increased CD86 and MHCII co-stimulatory molecules indicating activated phenotype, as well as intracellular IL-10, FASL and Granzyme B, molecules with regulatory immunosuppressive properties. Additionally, B cells showed high inhibitory upon T cell proliferation ex vivo, and a mild capacity to secrete antibodies. Our conclusion is that even when evidence of B cell-mediated activity of the immune response is present, B cells from TDLN exhibit regulatory phenotype and inhibitory activity, probably contributing to the state of immunological tolerance characteristic of the advanced tumor condition.


Subject(s)
Animals , Sarcoma/immunology , B-Lymphocytes, Regulatory/immunology , Immune Tolerance/immunology , Lymph Nodes/immunology , Antigens, Neoplasm/immunology , Phenotype , Sarcoma/pathology , Cell Count , T-Lymphocytes, Regulatory/immunology , Cell Line, Tumor , Cell Proliferation/physiology , Flow Cytometry , Lymph Nodes/pathology , Mice, Inbred BALB C
2.
Ortodontia ; 43(6): 639-647, nov.-dez. 2010. ilus, tab, graf
Article in Portuguese | LILACS, BBO | ID: lil-711968

ABSTRACT

A expansão palatal implantossuportada (Epis) permite a abertura da sutura palatina evitando os efeitos indesejáveis da expansão maxilar sobre as estruturas dentoalveolares. Os aparelhos da técnica Epis são ancorados por dois implantes inseridos próximos à sutura palatina mediana. Métodos: este estudo foi conduzido em três estágios: aparelhos Epis foram instalados e ativados em dois crânios humanos adultos para avaliação das deformações ósseas craniofaciais através de extensometria com strain gauges; foram criados tridimensionalmente (3D) um modelo do complexo nasomaxilar e um aparelho Epis os quais foram unidos e receberam propriedades físicas e condições de contorno apropriadas para análisepelo método dos elementos finitos (MEF); foi realizada avaliação clínica de dois aparelhos instalados em pacientes adultos com necessidade de expansão maxilar. Os resultados dos strain gauges validaram qualitativamente os resultados do MEF pela coincidência dos locaiscom tensões trativas e compressivas nos modelos 3D mostrando o bom desempenho biomecânico da expansão palatal com aparelhos Epis. Estes locais também correspondem às áreas clinicamente consideradas como de alta resistência à expansão maxilar. A avaliação in vivo mostrou a facilidade de instalação e remoção do aparelho. Conclusão: a expansão palatal implantossuportada pode ser empregada com ou sem auxílio cirúrgico, dependendo da resistência óssea, sendo sua principal indicação na constrição maxilar com poucos dentesposteriores para ancoragem ou com limitações periodontais.


The implant supported palatal expander (Epis) was developed to eliminatethe undesirable effects on dentoalveolar structures due to upper jaw expansion. The Epis devices are anchored by two implants placed near the mid palatal suture. Methods: this study was conducted on three steps: Eois were installed and activated in two human adult skulls for assessment of craniofacial bane deformations by strain gauges, a naso-maxillary modeland an Epis model were tridimensionally (3D) created, assembled and received physical properties and boundary conditions suitable for finite element methods (MEF) and clinical evaluation was carried out by installing Eois appliances in two adult patients in need of upper jaw expansion. Results: the strain gauges results qualitatively validated the MEF results on3D models by the coincidence of the sites with compressive and tensile stress showing the good biomechanics performance of the palatal expansion with Eois devices. Those sites alsocorrespond to the upper jaw areas considered clinically as high resistance to expansion. In vivo evaluation proves the facility to install and remove the device. Conclusions: the implantsupported palatal expansion can be employed with ar without surgical assistance, depends on bane resistance being its main indication in upper jaw constriction with few posterior teethfor anchor ar with periodontallimitations.


Subject(s)
Dental Implants , Palatal Expansion Technique , Sutures , Constriction , Finite Element Analysis , Malocclusion , Orthodontic Appliances , Palate
3.
Rev. argent. cardiol ; 74(3): 211-216, mayo-jun. 2006. tab, graf
Article in Spanish | LILACS | ID: lil-440342

ABSTRACT

Los datos del certificado de defunción no reflejan ajustadamente las causas y las circunstancias de la muerte. La comparación con otros métodos de información, como la autopsia verbal, podría demostrar las falencias de los registros. Objetivos: 1. Identificar las causas de muerte en 20 ciudades argentinas mediante la autopsia verbal y compararlas con las que constan en el certificado de defunción. 2. Analizar la muerte cardiovascular en cuanto a antecedentes y factores de riesgo. Material y métodos: Se incluyeron todos los mayores de 18 años fallecidos durante 2 meses del año 2004 en las ciudades participantes. Resultados: Se constataron 1274 muertes. Según la autopsia verbal, las causas de muerte cardiovascular más frecuentes fueron insuficiencia cardíaca (23 por ciento), accidente cerebrovascular (11,3 por ciento) e infarto de miocardio (8 por ciento) y las no cardiovasculares fueron neoplasias (21,5 por cierto), neumopatías (7,6 por ciento) e infecciones (6,6 por ciento). En el 11,7 por ciento de los fallecidos no se pudo establecer claramente la causa de muerte según el certificado.La concordancia de ambos métodos para definir la causa de muerte según el coeficiente V de Cramer fue de 0,608, el valor de kappa fue de 0,614 (0,580-0,647) y el de kappa ponderado fue de 0,596 (0,555-0,637). Existió un subregistro del 9,7 por ciento de insuficiencia cardíaca según el certificado y un sobrerregistro del 6,4 por ciento en muerte por otras causas cardiovasculares conrespecto a la autopsia verbal. Los fallecidos de causa cardiovascular presentaron con más frecuencia factores de riesgo y antecedentes cardiovasculares. Conclusiones: En un porcentaje elevado de certificados de defunción no se pudo establecer claramente la causa de muerte. La mayor discordancia se registró en la muerte por insuficiencia cardíaca y otras causas cardiovasculares.


Subject(s)
Humans , Adult , Middle Aged , Aged, 80 and over , Disease , Epidemiology , Cardiovascular Diseases/mortality , Mortality , Argentina , Autopsy/methods , Death Certificates
SELECTION OF CITATIONS
SEARCH DETAIL